VistaGen Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
VTGN
CUSIP
92840H400
Type
Equity
Class
COM
Num filings
55
Total reported value, excl. options
$45.3 M
Manager Report Date Value ($000) Shares Option Type